The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.

The study suggests the tests could save lives by catching cancer at earlier stages, when it's more easily treated. It predicted that, over a decade of use, MCEDs could reduce stage IV cancer diagnoses ...

CVS says they are planning to expand their COVID-19 testing services. On Wednesday, the pharmacy chain announced that it would add rapid-result COVID testing at nearly 1,000 sites by the end of the ...

The US Food and Drug Administration cleared a number of molecular tests and immunoassays, as well as a clinical chemistry and a cellular deformation test.

If you have a mild illness like a cold, it’s fine to get a flu shot. If you’re already experiencing flu-like symptoms, like ...

Tracking how genes switch on and off in the brain is essential for understanding many neurological diseases, yet the tools to monitor this activity are often invasive or unable to capture subtler ...

Rocket Lab launched its hypersonic test vehicle for the sixth time ever this week. The HASTE suborbital rocket lifted off Tuesday (Nov. 18) at 8 a.m. EST (1300 GMT) from Rocket Lab's Launch Complex 2 ...

Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil exposure. These infections can affect both healthy and immunocompromised ...

Researchers at Dartmouth Hitchcock Medical Center have developed a way to diagnose Lyme disease earlier and more accurately than traditional testing methods. Over the past 30 years, Lyme disease has ...

Eric Gardner, owner of Any Lab Test Now in Kalispell. (Kate Heston/Daily Inter Lake) Medical supplies at Kalispell's Any Lab Test Now. (Kate Heston/Daily Inter Lake) Eric Gardner, owner of Any Lab ...

Many routine laboratory tests continue to be used, despite their limited diagnostic or patient management. Newer biomarkers offer more precise and clinically relevant data at similar costs, with ...

Sept 18 (Reuters) - The U.S. Food and Drug Administration will rescind a rule that tightened regulations for clinical laboratories and gave the agency more oversight of diagnostic tests developed by ...